Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Dec 29;48(1):204.
doi: 10.1186/s13052-022-01398-0.

Prader-Willi syndrome patient with atypical phenotypes caused by mosaic deletion in the paternal 15q11-q13 region: a case report

Affiliations
Case Reports

Prader-Willi syndrome patient with atypical phenotypes caused by mosaic deletion in the paternal 15q11-q13 region: a case report

Jinying Wu et al. Ital J Pediatr. .

Erratum in

Abstract

Background: Prader-Willi syndrome (PWS) is a multisystemic complex genetic disorder caused by the loss of paternally expressed genes in the human chromosome region 15q11.2-q13. It is characterized by severe hypotonia and feeding difficulties in early infancy, followed in later infancy or early childhood by excessive eating and gradual development of morbid obesity. Motor milestones and language development are delayed and most patients have intellectual disability.

Case presentation: Here we describe a rare PWS case caused by mosaic imprinting defect in the region 15q11.2-q13 of paternal origin. The proband was a male child with a clinical presentation of global developmental delay and hypotonia with specific facial features. Karyotype of the child was noted as mosaic: 45XY,der(15)?t(15;21),-21[26]/46,XY[24]. Whole-exome sequencing (WES) identified a deletion of 22.7 Mb in size at chr15q11.2q21.1 region and a deletion of 2.1 Mb in size at chr21q22.3 region. The Methylation-specific multiplex ligation-dependent probe amplification(MS-MLPA) of the 15q11.2-q13 region showed that the loading ratio of methylated alleles was 70% and that of unmethylated alleles was 30%(50% normal), which confirmed that the loss of mosaic imprinted defects in the paternal allele led to the diagnosis of PWS.

Conclusions: We propose that complete clinical criteria for PWS should not be considered sensitive in diagnosing partial atypical PWS due to mosaic imprinting defects. In contrast, clinical suspicion based on less restrictive criteria followed by multiple techniques is a more powerful approach.

Keywords: Atypical Prader-Willi syndrome; Case report; Imprinting defect; Mosaicism; Multi-technology combined diagnosis.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing interests related to the study.

Figures

Fig. 1
Fig. 1
Chromosome karyotype analysis of peripheral blood lymphocytes of children 1a:G-banding in metaphase of peripheral blood lymphocyte division showed chromosome karyotype 46,XY1b:G-banding in metaphase of peripheral blood lymphocyte division showed chromosome karyotype 45XY,der(15)?t(15;21),-21 [1]/46,XY [2])
Fig. 2
Fig. 2
Whole exome sequencing results (There is a fragment deletion on chromosome 15 in the child, and the red arrow shows the deletion region)
Fig. 3
Fig. 3
15q11.2-q13 region MLPA analysis results

Similar articles

Cited by

References

    1. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108:E92. doi: 10.1542/peds.108.5.e92. - DOI - PubMed
    1. Onis MD, Martorell R, Garza C, Lartey A. WHO child growth standards based on length/height, weight and age. Acta Paediatr. 2006;95:76–85. - PubMed
    1. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Investig. 2015;38:1249–1263. doi: 10.1007/s40618-015-0312-9. - DOI - PMC - PubMed
    1. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14:10–26. doi: 10.1038/gim.0b013e31822bead0. - DOI - PubMed
    1. Dagdeviren CA, Bas F, Akin O, Siklar Z, Ozcabi B, Berberoglu M, Kardelen AD, Bayramoglu E, Poyrazoglu S, Aydin M, Torel EA, Goksen D, Bolu S, Aycan Z, Tuysuz B, Ercan O, Evliyaoglu O. Clinical characteristics and growth hormone treatment in patients with Prader-Willi syndrome. J Clin Res Pediatr Endocrinol. 2021;13:308–319. doi: 10.4274/jcrpe.galenos.2021.2020.0228. - DOI - PMC - PubMed

Publication types